Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Prostatic Neoplasms 7 Lymphoma 5 Burkitt Lymphoma 5 Neoplasms 4 Leukemia, Biphenotypic, Acute 4 Ovarian Neoplasms 3 Lymphoma, Follicular 3 Hodgkin Disease 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Leukemia 2 Endometrial Neoplasms 2 Down Syndrome 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Heart Failure 1 Enteropathy-Associated T-Cell Lymphoma 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Radiosurgery 50 Magnetic Resonance Spectroscopy 34 Temozolomide 28 Bevacizumab 24 pembrolizumab 23 Radiotherapy 20 Nivolumab 20 Specimen Handling 14 Ipilimumab 13 Cyclophosphamide 13 Mental Status and Dementia Tests 12 Carboplatin 12 abemaciclib 10 Radiation 10 trastuzumab deruxtecan 8 Proton Therapy 7 Pemetrexed 7 Memantine 7 Blood Specimen Collection 7 fluciclovine F-18 6 binimetinib 6 Paclitaxel 6 Lomustine 6 Etoposide 6 Cisplatin 6 Capecitabine 6 encorafenib 5 Trastuzumab 5 Surveys and Questionnaires 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Prednisolone × 1 year × Clear all

NCT06471465 2025-08-17

BRADI

Institut Cancerologie de l'Ouest

Phase 3 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡